{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:12:49Z","timestamp":1791943969930,"version":"4.3.4"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2026,1]]},"abstract":"\n Key Points<\/jats:title>\n \n \n \n Significant heterogeneity in patient characteristics, urine metabolic studies, and kidney outcomes exist among enteric hyperoxaluria patients from diverse etiologies.<\/jats:p>\n <\/jats:list-item>\n \n Structurally induced malabsorption and exocrine pancreatic insufficiency have the highest kidney stone event rates.<\/jats:p>\n <\/jats:list-item>\n \n Patients with structurally induced malabsorption have up to 18% ESKD incidence at 5 years.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n Enteric hyperoxaluria (EH) is a risk factor for calcium oxalate nephrolithiasis and kidney disease. The study compares patient characteristics and urine metabolic profiles at the time of EH diagnosis and kidney stones and ESKD events during follow-up in a cohort with diverse causes of EH.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Adult patients with newly documented elevated urinary oxalate excretion >40 mg\/24 h between January 1, 2010, and October 10, 2023, and a known enteric diagnosis including inflammatory bowel disease, exocrine pancreatic insufficiency (EPI), celiac disease, structural intestinal malabsorption (SIM), or malabsorptive bariatric surgery (Bariatric) were identified. Event rates and cumulative incidence of kidney stones and ESKD were assessed.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Among 814 identified patients, the most common enteric etiology was Bariatric (\n n<\/jats:italic>\n =524, 64%). Patients with ulcerative colitis had the highest prevalence of kidney stones at EH diagnosis (93.6%) compared with other enteric etiologies (\n P<\/jats:italic>\n = 0.002). Patients with SIM had the highest urinary oxalate, lower urinary citrate, and volume, compared with other enteric etiologies (\n P<\/jats:italic>\n < 0.05). Calcium oxalate supersaturation was similar among the enteric groups (\n P<\/jats:italic>\n = 0.67). Median stone event rate for the overall cohort was 0.70 stone events\/year during a mean (SD) follow-up of 5.0 (3.9) years. The SIM and EPI groups experienced the highest stone events (median [IQR] 1.24 [0.28\u20132.40] and 1.20 [0.41\u20131.99] events\/year, respectively) while the Bariatric group had the lowest event rates (median [IQR] 0.45 [0.00\u20131.66 events\/year];\n P<\/jats:italic>\n < 0.001). The SIM group had the highest ESKD incidence (17.8% 5 years postdiagnosis; log-rank test\n P<\/jats:italic>\n < 0.001).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n We describe a large EH cohort from diverse enteric etiologies. Significant heterogeneity exists in patient characteristics, urine metabolic risk factors, and adverse kidney outcomes. Patients with SIM and EPI experienced the highest kidney stone events and patients with SIM had the highest ESKD incidence. This study highlights the urgent need for more granular information regarding the natural history and risk factors for kidney complications for patients with EH to support interventional trials to improve outcomes.<\/jats:p>\n <\/jats:sec>","DOI":"10.34067\/kid.0000000908","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T16:00:37Z","timestamp":1754928037000},"page":"164-176","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Kidney Stone Events and ESKD Incidence in Patients with Enteric Hyperoxaluria from Diverse Enteric Etiologies"],"prefix":"10.34067","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1880-1282","authenticated-orcid":false,"given":"Ryan W.","family":"Tatton","sequence":"first","affiliation":[{"name":"Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5992-4003","authenticated-orcid":false,"given":"Stephen R.","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9680-3124","authenticated-orcid":false,"given":"Deondre","family":"Jordan","sequence":"additional","affiliation":[{"name":"Mayo Foundation for Medical Education and Research, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5159-7738","authenticated-orcid":false,"given":"Lisa E.","family":"Vaughan","sequence":"additional","affiliation":[{"name":"Mayo Foundation for Medical Education and Research, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0202-5944","authenticated-orcid":false,"given":"John C.","family":"Lieske","sequence":"additional","affiliation":[{"name":"Mayo Foundation for Medical Education and Research, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8249-0848","authenticated-orcid":false,"given":"Mira T.","family":"Keddis","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"issue":"4","key":"B1-20260129","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/JU.0000000000002331","article-title":"Incidence of kidney stones in the United States: the continuous national health and nutrition examination survey","volume":"207","author":"Hill","year":"2022","journal-title":"J Urol."},{"issue":"1","key":"B2-20260129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00240-020-01210-w","article-title":"Trends in the prevalence of kidney stones in the United States from 2007 to 2016","volume":"49","author":"Chewcharat","year":"2021","journal-title":"Urolithiasis."},{"issue":"4","key":"B3-20260129","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/end.2015.0676","article-title":"Prevalence of hyperoxaluria in urinary stone formers: chronological and geographical trends and a literature review","volume":"30","author":"Spradling","year":"2016","journal-title":"J Endourol."},{"issue":"6","key":"B4-20260129","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM197702102960602","article-title":"Importance of the colon in enteric hyperoxaluria","volume":"296","author":"Dobbins","year":"1977","journal-title":"N Engl J Med."},{"issue":"3","key":"B5-20260129","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.08000520","article-title":"Pathophysiology and treatment of enteric hyperoxaluria","volume":"16","author":"Witting","year":"2021","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B6-20260129","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/nu16020264","article-title":"Intestinal oxalate absorption, enteric hyperoxaluria, and risk of urinary stone formation in patients with crohn's disease","volume":"16","author":"Siener","year":"2024","journal-title":"Nutrients."},{"issue":"1","key":"B7-20260129","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.soard.2013.03.014","article-title":"Calcium oxalate supersaturation increases early after Roux-en-Y gastric bypass","volume":"10","author":"Agrawal","year":"2014","journal-title":"Surg Obes Relat Dis."},{"issue":"10","key":"B8-20260129","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s11695-013-0916-0","article-title":"Urinary evaluation after RYGBP: a lithogenic profile with early postoperative increase in the incidence of urolithiasis","volume":"23","author":"Valezi","year":"2013","journal-title":"Obes Surg."},{"issue":"2","key":"B9-20260129","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000448766","article-title":"A double-blind, placebo controlled, randomized phase 1 cross-over study with ALLN-177, an orally administered oxalate degrading enzyme","volume":"44","author":"Langman","year":"2016","journal-title":"Am J Nephrol."},{"issue":"7","key":"B10-20260129","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00467-012-2126-8","article-title":"Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn's disease","volume":"27","author":"Hueppelshaeuser","year":"2012","journal-title":"Pediatr Nephrol."},{"issue":"3","key":"B11-20260129","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.juro.2008.05.007","article-title":"Urinary stone disease in adults with celiac disease: prevalence, incidence and urinary determinants","volume":"180","author":"Ciacci","year":"2008","journal-title":"J Urol."},{"issue":"3","key":"B12-20260129","doi-asserted-by":"crossref","first-page":"e0194019","DOI":"10.1371\/journal.pone.0194019","article-title":"Association between chronic pancreatitis and urolithiasis: a population-based cohort study","volume":"13","author":"Chen","year":"2018","journal-title":"PLoS One."},{"issue":"3","key":"B13-20260129","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pan.2023.03.006","article-title":"Pancreatic exocrine insufficiency is a risk factor for kidney stones in patients with chronic pancreatitis","volume":"23","author":"Vujasinovic","year":"2023","journal-title":"Pancreatology."},{"issue":"5","key":"B14-20260129","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.soard.2005.07.002","article-title":"Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass","volume":"1","author":"Nelson","year":"2005","journal-title":"Surg Obes Relat Dis."},{"issue":"4","key":"B15-20260129","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrneph.2017.10","article-title":"Crystal nephropathies: mechanisms of crystal-induced kidney injury","volume":"13","author":"Mulay","year":"2017","journal-title":"Nat Rev Nephrol."},{"issue":"3","key":"B16-20260129","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/ndt\/gfv005","article-title":"Enteric hyperoxaluria: an important cause of end-stage kidney disease","volume":"31","author":"Nazzal","year":"2016","journal-title":"Nephrol Dial Transplant."},{"issue":"12","key":"B17-20260129","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1159\/000520286","article-title":"Clinical outcomes and histological patterns in oxalate nephropathy due to enteric and nonenteric risk factors","volume":"52","author":"Reddy","year":"2021","journal-title":"Am J Nephrol."},{"issue":"2","key":"B18-20260129","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/ajt.12029","article-title":"Enteric oxalate nephropathy in the renal allograft: an underrecognized complication of bariatric surgery","volume":"13","author":"Troxell","year":"2013","journal-title":"Am J Transplant."},{"issue":"9","key":"B19-20260129","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1681\/ASN.2020121793","article-title":"High oxalate concentrations correlate with increased risk for sudden cardiac death in dialysis patients","volume":"32","author":"Pfau","year":"2021","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B20-20260129","doi-asserted-by":"crossref","first-page":"109420","DOI":"10.1016\/j.celrep.2021.109420","article-title":"Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis","volume":"36","author":"Liu","year":"2021","journal-title":"Cell Rep."},{"issue":"2","key":"B21-20260129","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.ajkd.2024.02.010","article-title":"24-Hour urinary chemistries and kidney stone risk","volume":"84","author":"Ferraro","year":"2024","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"B22-20260129","doi-asserted-by":"crossref","first-page":"F409","DOI":"10.1152\/ajprenal.00373.2018","article-title":"Dietary oxalate and kidney stone formation","volume":"316","author":"Mitchell","year":"2019","journal-title":"Am J Physiol Renal Physiol."},{"issue":"4","key":"B23-20260129","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.ki.5002708","article-title":"24-h uric acid excretion and the risk of kidney stones","volume":"73","author":"Curhan","year":"2008","journal-title":"Kidney Int."},{"issue":"19","key":"B25-20260129","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New Creatinine- and cystatin C-Based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med."},{"issue":"2","key":"B26-20260129","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11255-009-9602-5","article-title":"Hyperoxaluria after modern bariatric surgery: case series and literature review","volume":"42","author":"Whitson","year":"2010","journal-title":"Int Urol Nephrol."},{"issue":"5","key":"B27-20260129","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.surg.2010.11.015","article-title":"Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery","volume":"149","author":"Kumar","year":"2011","journal-title":"Surgery."},{"issue":"4","key":"B28-20260129","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ki.2014.352","article-title":"Kidney stones are common after bariatric surgery","volume":"87","author":"Lieske","year":"2015","journal-title":"Kidney Int."},{"issue":"6","key":"B29-20260129","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.juro.2009.02.029","article-title":"Effect of gastric bypass surgery on kidney stone disease","volume":"181","author":"Matlaga","year":"2009","journal-title":"J Urol."},{"issue":"3","key":"B30-20260129","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.juro.2009.11.022","article-title":"Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery","volume":"183","author":"Maalouf","year":"2010","journal-title":"J Urol."},{"issue":"6","key":"B31-20260129","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jamcollsurg.2008.01.015","article-title":"Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis","volume":"206","author":"Duffey","year":"2008","journal-title":"J Am Coll Surg."},{"issue":"12","key":"B32-20260129","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/ndt\/gfaa281","article-title":"Subsequent urinary stone events are predicted by the magnitude of urinary oxalate excretion in enteric hyperoxaluria","volume":"36","author":"D'Costa","year":"2021","journal-title":"Nephrol Dial Transplant."},{"issue":"12","key":"B33-20260129","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1440-1746.2004.03510.x","article-title":"Infrequency of colonization with oxalobacter formigenes in inflammatory bowel disease: possible role in renal stone formation","volume":"19","author":"Kumar","year":"2004","journal-title":"J Gastroenterol Hepatol."},{"issue":"2","key":"B34-20260129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat Microbiol."},{"issue":"4","key":"B35-20260129","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0002-9343(78)90576-4","article-title":"Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias. Effect of calcium and magnesium","volume":"64","author":"Barilla","year":"1978","journal-title":"Am J Med."},{"issue":"4","key":"B36-20260129","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ki.1990.265","article-title":"Renal handling of citrate","volume":"38","author":"Hamm","year":"1990","journal-title":"Kidney Int."},{"issue":"2","key":"B37-20260129","doi-asserted-by":"crossref","first-page":"310 e9","DOI":"10.1016\/j.urology.2018.06.061","article-title":"The effect of calcium and vitamin B6 supplementation on oxalate excretion in a rodent gastric bypass model of enteric hyperoxaluria","volume":"124","author":"Espino-Grosso","year":"2019","journal-title":"Urology."},{"issue":"1","key":"B38-20260129","first-page":"371","article-title":"Renal stone formation in patients with inflammatory bowel disease","volume":"7","author":"Caudarella","year":"1993","journal-title":"Scanning Microsc."},{"issue":"4","key":"B39-20260129","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/MNH.0000000000000229","article-title":"Oxalate, inflammasome, and progression of kidney disease","volume":"25","author":"Ermer","year":"2016","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"5","key":"B40-20260129","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ki.2013.207","article-title":"NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy","volume":"84","author":"Knauf","year":"2013","journal-title":"Kidney Int."},{"issue":"3","key":"B41-20260129","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1681\/ASN.2016040486","article-title":"Hyperoxaluria requires TNF receptors to initiate crystal adhesion and kidney stone disease","volume":"28","author":"Mulay","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B42-20260129","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1172\/JCI63679","article-title":"Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1\u03b2 secretion","volume":"123","author":"Mulay","year":"2013","journal-title":"J Clin Invest."},{"key":"B43-20260129","doi-asserted-by":"crossref","first-page":"1157696","DOI":"10.3389\/fped.2023.1157696","article-title":"Frequency and impact of enteric hyperoxaluria in pediatric short bowel syndrome: a retrospective single centre study","volume":"11","author":"Schaefer","year":"2023","journal-title":"Front Pediatr."},{"issue":"7","key":"B44-20260129","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/ajt.12305","article-title":"Combined kidney and intestinal transplantation in patients with enteric hyperoxaluria secondary to short bowel syndrome","volume":"13","author":"Ceulemans","year":"2013","journal-title":"Am J Transplant."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:59:26Z","timestamp":1786478366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000908","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"2025-04-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}